# FDA Inspection 1231467 - Kedrion Biopharma Inc. - March 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/d762365d-3809-4cfa-9df5-a396fdf950c4
Source feed: FDA_Inspections

> FDA Inspection 1231467 for Kedrion Biopharma Inc. on March 27, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231467
- Company Name: Kedrion Biopharma Inc.
- Inspection Date: 2024-03-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1148187 - 2021-06-25](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/6af60139-33bc-4215-b0b0-bced6a25cb54)
- [FDA Inspection 1064655 - 2018-08-29](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/65d6df47-9734-470a-9896-5df11ddf3333)
- [FDA Inspection 900509 - 2014-09-29](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/e903e6b6-2376-4795-b0d6-de8aefe60a7f)
- [FDA Inspection 801013 - 2012-08-02](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/acd1b3b7-303c-4957-83fb-735492cefa0a)
- [FDA Inspection 610974 - 2009-07-21](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/84ff9249-42d2-4b1e-a42b-b129592a2faa)

Company: https://www.keypedia.com/companies/kedrion-biopharma-inc/e6cf606f-c996-4278-ad90-ec69fbd2a7f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d